This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Super Micro Computer and Walgreens Boots Alliance have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Super Micro Computer and Walgreens Boots Alliance are part of the Zacks Bull and Bear of the Day article.
Bear of the Day: Walgreens Boots Alliance (WBA)
by Derek Lewis
Margin pressures and lowered guidance paint a challenging picture for the company's shares in the near term.
Walgreens Boots (WBA) Q3 Earnings Miss, Gross Margin Down
by Zacks Equity Research
An increasingly challenging pharmacy industry and consumer environment hurt Walgreens Boots' (WBA) bottom line in the third quarter of fiscal 2024.
Nike and Walgreens Boot Alliance are part of Zacks Earnings Preview
by Zacks Equity Research
Nike and Walgreens Boot Alliance are highlights of Zacks Earnings Preview article.
Q2 Earnings Growth Forecasted to Hit Two-Year High
by Sheraz Mian
Q2's expected quarterly earnings growth pace of +8.3% reflects the strongest growth since back in Q1 of 2022. Tech is expected to do some heavy lifting again, with earnings expected to be up +15.5% on +9.5% higher revenues.
Top and Flop ETFs of the First Half
by Sweta Killa
We have highlighted three ETFs each from the best and worst-performing zones in the first half of 2024.
Cencora (COR) Stock Nosedives: Here's What Caused the Decline
by Zacks Equity Research
Cencora (COR) shares declined on Jun 27, following an unfavorable ruling from the Supreme Court related to a previously settled litigation. Here we discuss the key factors that likely led to the decline.
Initial Claims Lower-Than-Expected
by Zacks Equity Research
Initial Claims Lower-Than-Expected.
Jobless Claims Up, Consumption Down; Walgreens Down Big
by Mark Vickery
New jobless claims shrank a tad, but longer-term came in the highest in 2 1/2 years.
Here's What Key Metrics Tell Us About Walgreens (WBA) Q3 Earnings
by Zacks Equity Research
The headline numbers for Walgreens (WBA) give insight into how the company performed in the quarter ended May 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Walgreens Boots Alliance (WBA) Q3 Earnings Miss Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of -5.97% and 1.07%, respectively, for the quarter ended May 2024. Do the numbers hold clues to what lies ahead for the stock?
Micron, Levi's Trade Down After Market on Earnings
by Mark Vickery
After finishing mostly in the green today, late trading has gotten harsh for MU and LEVI.
Exploring Analyst Estimates for Walgreens (WBA) Q3 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of Walgreens (WBA) for the quarter ended May 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Why the Market Dipped But Walgreens Boots Alliance (WBA) Gained Today
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $15.97 in the latest trading session, marking a +0.63% move from the prior day.
Earnings Preview: Walgreens Boots Alliance (WBA) Q3 Earnings Expected to Decline
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bear of the Day: CVS Health (CVS)
by Andrew Rocco
Drugstore giant CVS faces numerous bearish headwinds, which are industry and company-specific. Investors should avoid shares over the next 6-12 months.
Why the Market Dipped But Walgreens Boots Alliance (WBA) Gained Today
by Zacks Equity Research
In the closing of the recent trading day, Walgreens Boots Alliance (WBA) stood at $15.55, denoting a +0.65% change from the preceding trading day.
Zacks Investment Ideas feature highlights: AT&T, Verizon, Advanced Micro Devices, Walgreens Boots Alliance and Apple
by Zacks Equity Research
AT&T, Verizon, Advanced Micro Devices, Walgreens Boots Alliance and Apple have been highlighted in this Investment Ideas article.
Cheaper isn't Always Better: How to Avoid the Stock Value Trap
by Andrew Rocco
Cheap valuations do not automatically make a stock a value proposition. In fact, investors who chase low valuation stocks will often get caught in value traps that underperform the market.
Walgreens Boots Alliance (WBA) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $15.94 in the latest trading session, marking a +0.63% move from the prior day.
What You Should Know About Dividend Paying Stocks
by Derek Lewis
Dividend payments are essentially investors' versions of paydays. But what should investors know about dividend-paying stocks?
Big Lots (BIG) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Big Lots (BIG) delivered earnings and revenue surprises of -6.62% and 3.03%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
2 Stocks to Watch & One to Avoid From the Volatile Retail Pharmacy Industry
by Urmimala Biswas
Zacks Retail-Pharmacies and Drug Stores industry players like WBA and HLF are likely to gain despite reimbursement challenges that are hurting the overall health of the industry. CVS might struggle in the face of economic challenges.
Walgreens Boots Alliance (WBA) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
Walgreens Boots Alliance (WBA) reachead $15.92 at the closing of the latest trading day, reflecting a -1.85% change compared to its last close.
Walgreens Boots Alliance (WBA) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
Walgreens Boots Alliance (WBA) concluded the recent trading session at $16.03, signifying a +0.5% move from its prior day's close.